Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial

This study aims to investigate the efficacy of temporary clipping of the uterine artery and utero-ovarian ligament during robotically assisted myomectomy (RAM) for uterine fibroids. While RAM is increasingly used for myomectomy, bleeding control remains challenging. Temporary clipping of arteries has shown promise in conventional laparoscopy but has not been studied in RAM. This randomized controlled trial will assess primary endpoints such as estimated blood loss, need for transfusion, and hemoglobin drop, alongside secondary outcomes like complication rates and operation time.

Trial Details

NCT ID
NCT06269809
Phase
NA
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • Temporary clipping of the uterine arteries and the utero-ovarian ligmants.
  • No temporary clipping of the uterine arteries and the utero-ovarian ligmants.
Locations (sample)
  • Leuven, Belgium|50.87959,4.70093
  • Paris, France|48.85341,2.3488
  • Rennes, France|48.11109,-1.67431
  • Amsterdam, Netherlands|52.37403,4.88969

Key Eligibility Criteria

  • Participants eligible for inclusion in this Trial must meet all of the following criteria:
  • Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  • Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% pe…
  • Age: 18-50 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →